Cargando…
Plasma catestatin level predicts sPESI score and mortality in acute pulmonary embolism
INTRODUCTION: Acute pulmonary embolism (APE) is an emergent cardiothoracic disorder. The PESI score is used to estimate 30-day mortality in patients diagnosed with non-high-risk APE. Also, there are biomarkers for predicting prognosis and mortality in APE. Catestatin (CST) is accepted as a marker of...
Autores principales: | Izci, Servet, Acar, Emrah, Inanir, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277442/ https://www.ncbi.nlm.nih.gov/pubmed/32529106 http://dx.doi.org/10.5114/amsad.2020.95562 |
Ejemplares similares
-
Assessment of Renal Dysfunction Improves the Simplified Pulmonary Embolism Severity Index (sPESI) for Risk Stratification in Patients with Acute Pulmonary Embolism
por: Trimaille, Antonin, et al.
Publicado: (2019) -
Can a modified-simplified pulmonary embolism severity index (m-sPESI) be used to predict the need for intensive care in hospitalized COVID-19 patients?
por: As, Ahmet Kagan, et al.
Publicado: (2021) -
The addition of echocardiographic parameters to PESI risk score improves mortality prediction in patients with acute pulmonary embolism: PESI-Echo score
por: Burgos, Lucrecia M, et al.
Publicado: (2020) -
Non-O-blood types associated with higher risk of high-grade atrioventricular block
por: Acar, Emrah, et al.
Publicado: (2019) -
Comparing three clinical prediction rules for primarily predicting the 30-day mortality of patients with pulmonary embolism: The “Simplified Revised Geneva Score,” the “Original PESI,” and the “Simplified PESI”
por: Tamizifar, Babak, et al.
Publicado: (2016)